Semaglutide (Wegovy) - A New Treatment for Weight Loss. 20 minute Drug Review. [SnA-A6KicdZ]

Semaglutide (Wegovy) - A New Treatment for Weight Loss. 20 minute Drug Review. [SnA-A6KicdZ]

| 1h 28m 28s | Video has closed captioning.

This video reviews the new use of the drug semalgutide (Wegovy) for the treatment of weight loss in obese and overweight individuals. Semaglutide is given as a once a week injection under the skin. Semaglutide is also known by the brand name Ozempic which is used for Type 2 diabetes. Semaglutide is an injectable glucagon-like peptide-1 (GLP-1) receptor agonist. It acts as an incretin hormone that plays a role in appetite, digestion, gastric emptying, and satiety. Dosage should be slowly titrated upward to avoid gastrointestinal side effects. Instructions on how to administer the drug via a pen device will be covered. Semaglutide should not be used by anyone with a family history of thyroid cancer. In clinical studies, semaglutide resulted in a 15% decrease in body weight from baseline. The drug is expensive, with a monthly cost of $1300. #vital keto gummies #luxe weight loss gummies #weight loss pill phentermine